High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations
2023; Elsevier BV; Volume: 142; Issue: 5 Linguagem: Inglês
10.1182/blood.2023019634
ISSN1528-0020
AutoresMoritz Fürstenau, Yvonne J. Thus, Sandra Robrecht, Clemens Mellink, Anne-Marie Van Der Kevie-Kersemaekers, Julie Dubois, Julia von Tresckow, Michaela Patz, Michael Gregor, Patrick Thornton, Philipp B. Staber, Tamar Tadmor, Mark‐David Levin, Caspar da Cunha‐Bang, Christof Schneider, Christian Bjoern Poulsen, Thomas Illmer, Björn Schöttker, Ann Janssens, Ilse Christiansen, Thomas Nösslinger, Michaël Baumann, Holger Hebart, Tobias Gaska, Josien C. Regelink, Ellen C. Dompeling, Vesa Lindström, Gunnar Juliusson, Anouk Widmer, Jeroen S. Goede, Neta Goldschmidt, Florian Simon, Nisha De Silva, Anna-Maria Fink, Kirsten Fischer, Clemens‐Martin Wendtner, Matthias Ritgen, Monika Brüggemann, Eugen Tausch, Marcel Spaargaren, Eric Eldering, Stephan Stilgenbauer, Carsten Utoft Niemann, Michael Hallek, Barbara Eichhorst, Karl‐Anton Kreuzer, Arnon P. Kater,
Tópico(s)Lymphoma Diagnosis and Treatment
Referência(s)